Ubiquitin and Ubiquitin-Like Proteins Are Essential Regulators of DNA Damage Bypass

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Genomic instability, caused by DNA damage and mutations, is a key factor in cancer development.
• Normal cells use DNA damage bypass pathways like translesion synthesis (TLS) and template switching (TS) to maintain genome integrity.
• Tight regulation of these pathways, particularly TLS, via post-translational modifications like ubiquitination is essential to prevent mutagenesis.

Purpose of the Study:

• To review the critical roles of ubiquitin and ubiquitin-like proteins in regulating DNA damage bypass mechanisms in human cells.
• To explore how these regulatory processes are disrupted during cancer progression.
• To identify potential therapeutic strategies targeting these pathways in cancer treatment.

Main Methods:

• This is a review article, synthesizing existing research on DNA damage bypass and ubiquitination.
• Key literature on post-translational modifications, DNA repair pathways, and cancer biology was analyzed.
• The review focuses on the functional aspects and regulatory mechanisms discussed in published studies.

Main Results:

• Ubiquitin and ubiquitin-like proteins are central regulators of DNA damage bypass pathways, influencing their activation and suppression.
• Dysregulation of these ubiquitination-mediated processes contributes to cancer cell proliferation and resistance to chemotherapy.
• Specific polymerases involved in TLS require precise ubiquitination for fidelity and to prevent excessive replication stress.

Conclusions:

• Ubiquitin-mediated regulation of DNA damage bypass is vital for maintaining genomic stability and preventing cancer.
• Aberrant regulation of these pathways in cancer cells promotes tumorigenesis and chemoresistance.
• Targeting ubiquitin-dependent DNA damage bypass mechanisms presents a promising avenue for novel cancer therapies.